fda glp-1 compounding enforcement september 2025 New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our FDA Drug Recalls and Warnings:

Always consult with a healthcare professional before beginning any new peptide or supplement routine

For skin brightening effects: 500-1000mg daily

This sequence of reactions elucidates the transformation of methionine into cysteine through the transsulfuration pathway [35]

3 Like Comment Share Copy LinkedIn Facebook X To view or add a comment, sign in

Nutrients 8, 167

Glucagon-Like Peptide-1 (GLP-1) Medications: From Bench to Bedside From a surprising discovery in Gila-monster venom to todays headline-making weight-loss breakthroughs, glucagon-like peptide-1 (GLP-1) medications have transformed diabetes and obesity care in just two decades